Cifras calculadas a partir de notificaciones regulatorias oficiales — .
Datos financieros
ProfessionalIngresos, márgenes, ratio precio/beneficio y más con el plan Professional.
Pregúntale a la máquina
Busca y compara operaciones de iniciados, sociedades y sus estadísticas en lenguaje natural. Tu pregunta se convierte en una consulta sobre los datos disponibles, no en una conversación ni en asesoramiento de inversión.
Solo datos de TODOS MEDICAL LTD.. Sin búsqueda web. Se excluyen las estadísticas globales de cada iniciado.
Una búsqueda ejecutada consume un crédito, incluso sin resultados. Los errores y las preguntas no compatibles no consumen créditos.
Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv-Yafo, Israel.
Fuente de información de mercado · Sep 10, 2026
Identidad según la SEC · Sep 9, 2026
Cronología en el mercado · historial completo
6 compras9 ventas— precio de cierrebarra = volumen usd, escala √haz clic en un periodo para filtrar la tabla
| Iniciado | Tipo | Valor · USD | Detalle | |
|---|---|---|---|---|
| COMMISSIONG GERALDhistorial | Compra | — | SEC | |
| COMMISSIONG GERALD |
| Compra |
| $30K |
| SEC |
| COMMISSIONG GERALDhistorial | Compra | $31.5K | SEC |
| Strategic Investment Holdings, LLC | Venta | $5.9K | SEC |
| Strategic Investment Holdings, LLC | Venta | $6K | SEC |
| Strategic Investment Holdings, LLC | Venta | $137.9K | SEC |
| Strategic Investment Holdings, LLC | Venta | $5K | SEC |
| Strategic Investment Holdings, LLC | Compra | $1M | SEC |
| Strategic Investment Holdings, LLC | Venta | $5K | SEC |
| Strategic Investment Holdings, LLC | Compra | $1.5M | SEC |
| Strategic Investment Holdings, LLC | Venta | $7.5K | SEC |
| Strategic Investment Holdings, LLC | Venta | $7.5K | SEC |
| Strategic Investment Holdings, LLC | Compra | $1M | SEC |
| Strategic Investment Holdings, LLC | Venta | $92K | SEC |
| Strategic Investment Holdings, LLC | Venta | $6K | SEC |